134 related articles for article (PubMed ID: 21805601)
1. Incidence, timing, and predictors of valve dislodgment during TAVI with the Medtronic Corevalve System.
Van Mieghem NM; Schultz CJ; van der Boon RM; Nuis RJ; Tzikas A; Geleijnse ML; van Domburg RT; Serruys PW; de Jaegere PP
Catheter Cardiovasc Interv; 2012 Apr; 79(5):726-32. PubMed ID: 21805601
[TBL] [Abstract][Full Text] [Related]
2. Aortic annulus dimensions and leaflet calcification from contrast MSCT predict the need for balloon post-dilatation after TAVI with the Medtronic CoreValve prosthesis.
Schultz C; Rossi A; van Mieghem N; van der Boon R; Papadopoulou SL; van Domburg R; Moelker A; Mollet N; Krestin G; van Geuns RJ; Nieman K; de Feyter P; Serruys PW; de Jaegere P
EuroIntervention; 2011 Sep; 7(5):564-72. PubMed ID: 21930460
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome of transcatheter aortic valve implantation in patients with low-flow, low gradient aortic stenosis.
Gotzmann M; Lindstaedt M; Bojara W; Ewers A; Mügge A
Catheter Cardiovasc Interv; 2012 Apr; 79(5):693-701. PubMed ID: 21805576
[TBL] [Abstract][Full Text] [Related]
4. Determinants of aortic regurgitation after transcatheter aortic valve implantation. An observational study using multi-slice computed tomography-guided sizing.
Rahhab Z; El Faquir N; Rodríguez-Olivares R; Ren C; van Mieghem N; Geleijnse ML; Schultz C; van Domburg R; de Jaegere PP
J Cardiovasc Surg (Torino); 2017 Aug; 58(4):598-605. PubMed ID: 28128540
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics.
Saia F; Lemos PA; Bordoni B; Cervi E; Boriani G; Ciuca C; Taglieri N; Mariani J; Kalil Filho R; Marzocchi A
Catheter Cardiovasc Interv; 2012 Apr; 79(5):712-9. PubMed ID: 22109957
[TBL] [Abstract][Full Text] [Related]
6. Correlates on MSCT of paravalvular aortic regurgitation after transcatheter aortic valve implantation using the Medtronic CoreValve prosthesis.
Schultz CJ; Tzikas A; Moelker A; Rossi A; Nuis RJ; Geleijnse MM; van Mieghem N; Krestin GP; de Feyter P; Serruys PW; de Jaegere PP
Catheter Cardiovasc Interv; 2011 Sep; 78(3):446-55. PubMed ID: 21793166
[TBL] [Abstract][Full Text] [Related]
7. "Device landing zone" calcification, assessed by MSCT, as a predictive factor for pacemaker implantation after TAVI.
Latsios G; Gerckens U; Buellesfeld L; Mueller R; John D; Yuecel S; Syring J; Sauren B; Grube E
Catheter Cardiovasc Interv; 2010 Sep; 76(3):431-9. PubMed ID: 20506410
[TBL] [Abstract][Full Text] [Related]
8. Intraoperative 2D and 3D transoesophageal echocardiographic predictors of aortic regurgitation after transcatheter aortic valve implantation.
Gripari P; Ewe SH; Fusini L; Muratori M; Ng AC; Cefalù C; Delgado V; Schalij MJ; Bax JJ; Marsan NA; Tamborini G; Pepi M
Heart; 2012 Aug; 98(16):1229-36. PubMed ID: 22826560
[TBL] [Abstract][Full Text] [Related]
9. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M
J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
[TBL] [Abstract][Full Text] [Related]
10. Valve-in-valve implantation of Medtronic CoreValve prosthesis in patients with failing bioprosthetic aortic valves.
Linke A; Woitek F; Merx MW; Schiefer C; Möbius-Winkler S; Holzhey D; Rastan A; Ender J; Walther T; Kelm M; Mohr FW; Schuler G
Circ Cardiovasc Interv; 2012 Oct; 5(5):689-97. PubMed ID: 23048050
[TBL] [Abstract][Full Text] [Related]
11. Incidence and predictors of permanent pacemaker implantation following transcatheter aortic valve implantation: analysis from the German transcatheter aortic valve interventions registry.
Ledwoch J; Franke J; Gerckens U; Kuck KH; Linke A; Nickenig G; Krülls-Münch J; Vöhringer M; Hambrecht R; Erbel R; Richardt G; Horack M; Zahn R; Senges J; Sievert H;
Catheter Cardiovasc Interv; 2013 Oct; 82(4):E569-77. PubMed ID: 23475694
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome following Transcatheter Aortic Valve Implantation in patients with impaired left ventricular systolic function.
van der Boon RM; Nuis RJ; Van Mieghem NM; Benitez LM; van Geuns RJ; Galema TW; van Domburg RT; Geleijnse ML; Dager A; de Jaegere PP
Catheter Cardiovasc Interv; 2012 Apr; 79(5):702-10. PubMed ID: 22121094
[TBL] [Abstract][Full Text] [Related]
13. Surgical sutureless and transcatheter aortic valves: hemodynamic performance and clinical outcomes in propensity score-matched high-risk populations with severe aortic stenosis.
Kamperidis V; van Rosendael PJ; de Weger A; Katsanos S; Regeer M; van der Kley F; Mertens B; Sianos G; Ajmone Marsan N; Bax JJ; Delgado V
JACC Cardiovasc Interv; 2015 Apr; 8(5):670-7. PubMed ID: 25946438
[TBL] [Abstract][Full Text] [Related]
14. Predictors of moderate-to-severe paravalvular aortic regurgitation immediately after CoreValve implantation and the impact of postdilatation.
Takagi K; Latib A; Al-Lamee R; Mussardo M; Montorfano M; Maisano F; Godino C; Chieffo A; Alfieri O; Colombo A
Catheter Cardiovasc Interv; 2011 Sep; 78(3):432-43. PubMed ID: 21793168
[TBL] [Abstract][Full Text] [Related]
15. Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation.
Sinning JM; Ghanem A; Steinhäuser H; Adenauer V; Hammerstingl C; Nickenig G; Werner N
JACC Cardiovasc Interv; 2010 Nov; 3(11):1141-9. PubMed ID: 21087750
[TBL] [Abstract][Full Text] [Related]
16. Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence.
Détaint D; Lepage L; Himbert D; Brochet E; Messika-Zeitoun D; Iung B; Vahanian A
JACC Cardiovasc Interv; 2009 Sep; 2(9):821-7. PubMed ID: 19778769
[TBL] [Abstract][Full Text] [Related]
17. Impact of aortic valve calcification on the outcome of transcatheter aortic valve implantation: results from the prospective multicenter German TAVI registry.
Staubach S; Franke J; Gerckens U; Schuler G; Zahn R; Eggebrecht H; Hambrecht R; Sack S; Richardt G; Horack M; Senges J; Steinberg DH; Ledwoch J; Fichtlscherer S; Doss M; Wunderlich N; Sievert H;
Catheter Cardiovasc Interv; 2013 Feb; 81(2):348-55. PubMed ID: 22566406
[TBL] [Abstract][Full Text] [Related]
18. Transcatheter aortic valve implantation in patients with severe aortic valve stenosis and large aortic annulus, using the self-expanding 31-mm Medtronic CoreValve prosthesis: first clinical experience.
Nijhoff F; Agostoni P; Amrane H; Latib A; Testa L; Oreglia JA; De Marco F; Samim M; Bedogni F; Maisano F; Bruschi G; Colombo A; Van Boven AJ; Stella PR
J Thorac Cardiovasc Surg; 2014 Aug; 148(2):492-9.e1. PubMed ID: 24263005
[TBL] [Abstract][Full Text] [Related]
19. Sex differences in postprocedural aortic regurgitation and mid-term mortality after transcatheter aortic valve implantation.
Ferrante G; Pagnotta P; Petronio AS; Bedogni F; Brambilla N; Fiorina C; Giannini C; Mennuni M; De Marco F; Klugmann S; Ettori F; Presbitero P
Catheter Cardiovasc Interv; 2014 Aug; 84(2):264-71. PubMed ID: 24408011
[TBL] [Abstract][Full Text] [Related]
20. Treatment of a degenerative stenosed CoreValve(®) aortic bioprosthesis by transcatheter valve-in-valve insertion.
Hammerstingl C; Nickenig G; Grube E
Catheter Cardiovasc Interv; 2012 Apr; 79(5):748-55. PubMed ID: 21735534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
